Approval · Notice of Compliance 20869 · 2018
HALAGON: Notice of Compliance 20869
Issued May 17, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20869
- Date
- May 17, 2018
- Company
- Emdoka BvbaHoogstraten, Antwerpen, Belgium
- Product type
- Veterinary
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- HALOCUR (Intervet Canada Corp)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HALAGON | Not yet assigned | — |
Medicinal ingredients
- HALOFUGINONE LACTATE 0.5 MG per ML